Arkolith/Insider Trading/IDYA/Form 4

Throne Jason

Chief Legal OfficerIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Nov 7, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$155K
Net Open-Market Flow
-$155K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 3, 2023Option exercise(M)5K$12.86$66K5K
Nov 3, 2023Sell(S)5K$30.09$155K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 3, 2023Option exercise(M)5K—$049K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000322) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML